COVID-19 pandemic
The French Haute Autorité de santé approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years.
Sources: France 24
Changes
- The French Haute Autorité de santé approves the usage of the Pfizer–BioNTech COVID-19 vaccine for all children aged 5–11 years old.
- Thailand's Food and Drug Administration approves the usage of the Pfizer–BioNTech COVID-19 vaccine for all children aged 5–11 years old.
- Thailand's Food and Drug Administration approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years.
- The French Haute Autorité de santé approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years.